← Leaderboards
Xiaoping Zhu
Univ Of Maryland, College Park
$8,417,631
Attributed
$11,277,283
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,277,283 · 11
By mechanism
R01$8,606,187 · 4
R21$2,491,096 · 6
R56$180,000 · 1
Top collaborators
- Shaik O Rahaman4 shared
- Charles David Pauza3 shared
- Jeffrey J Destefano2 shared
- Edmund J Gosselin2 shared
- Margaret Adele Scull2 shared
- Maria S. Salvato1 shared
Most similar at Univ Of Maryland, College Park
Same institution · by research overlap
- Shaik O Rahaman$2,282,599
- Wenquan Ou$1,169,677
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProteinsMediatingImmune ResponseEpithelial CellsInfectionImmunizationImmunityAntigensTissuesImmunePreventVaccinesPathogenMucous MembraneAntibodiesNeonatal Fc ReceptorImmunoglobulin GPathway InteractionsIn VivoMucosal ImmunityRouteVirusVirus Diseases
Grant awards (31)
Fc receptor-mediated delivery of therapeutics in airway inflammation$180,000
R56 · FY2025 · AI · contact PI
FcRn-Targeted Mucosal Vaccination Against Influenza Infections$539,122
R01 · FY2023 · AI · contact PI
FcRn-Targeted Mucosal Vaccination Against Influenza Infections$542,057
R01 · FY2022 · AI · contact PI
Development and Evaluation of Novel Aptamer-based Therapeutics Targeting SARS-CoV-2 in a Physiologically-Relevant Model of Human Airway Epithelium$193,125
R21 · FY2022 · AI
FcRn-Targeted Mucosal Vaccination Against Influenza Infections$552,555
R01 · FY2021 · AI · contact PI
Development and Evaluation of Novel Aptamer-based Therapeutics Targeting SARS-CoV-2 in a Physiologically-Relevant Model of Human Airway Epithelium$231,750
R21 · FY2021 · AI
FcRn-Targeted Mucosal Vaccination Against Influenza Infections$535,877
R01 · FY2020 · AI · contact PI
Role of TRPV4 mechanotransduction in foreign body response$419,197
R01 · FY2020 · EB
FcRn-Targeted Mucosal Vaccination Against Influenza Infections$554,124
R01 · FY2019 · AI · contact PI
Role of TRPV4 mechanotransduction in foreign body response$426,037
R01 · FY2019 · EB
Development of an adjuvant-free mucosal vaccine platform via sequential FcRn-mediated transepithelial Ag transport to the NALT and Fc RI-enhanced Ag processing and presentation within the NALT.$197,813
R21 · FY2019 · AI
Viral Immune Evasion of FcRn Functions$190,000
R21 · FY2019 · AI · contact PI
Role of TRPV4 mechanotransduction in foreign body response$435,613
R01 · FY2018 · EB
Development of an adjuvant-free mucosal vaccine platform via sequential FcRn-mediated transepithelial Ag transport to the NALT and Fc RI-enhanced Ag processing and presentation within the NALT.$252,563
R21 · FY2018 · AI
Viral Immune Evasion of FcRn Functions$228,000
R21 · FY2018 · AI · contact PI
Role of TRPV4 mechanotransduction in foreign body response$435,613
R01 · FY2017 · EB
FcRn-targeted mucosal HIV vaccine$746,981
R01 · FY2015 · AI
FcRn-targeted mucosal HIV vaccine$746,981
R01 · FY2014 · AI
FcRn-targeted mucosal HIV vaccine$716,450
R01 · FY2013 · AI
CD23-mediated immunotherapy on airway inflammation$178,600
R21 · FY2013 · AI · contact PI
FcRn-targeted mucosal HIV vaccine$775,556
R01 · FY2012 · AI
CD23-mediated immunotherapy on airway inflammation$228,000
R21 · FY2012 · AI · contact PI
Transcytosis of IgG in Genital Infections$252,388
R01 · FY2010 · AI · contact PI
Transcytosis of IgG in Genital Infections$139,300
R01 · FY2010 · AI · contact PI
Transcytosis of IgG in Genital Infections$254,937
R01 · FY2009 · AI · contact PI
Transcytosis of IgG in Genital Infections$254,937
R01 · FY2008 · AI · contact PI
AIDS Vaccine Strategy Using IgG Transfer Pathway$183,938
R21 · FY2008 · AI · contact PI
Transcytosis of IgG in Genital Infections$278,462
R01 · FY2007 · AI · contact PI
AIDS Vaccine Strategy Using IgG Transfer Pathway$214,500
R21 · FY2007 · AI · contact PI
Immunogenicity of Subunit Vaccine Delivered by FcRn$180,242
R21 · FY2007 · AI · contact PI
Immunogenicity of Subunit Vaccine Delivered by FcRn$212,565
R21 · FY2006 · AI · contact PI